Monitor the special meeting outcome on October 23, 2026, for the reverse stock split approval. If passed, the Board may implement a split at any ratio up to 1-for-500 within 12 months. The stock remains non-compliant with Nasdaq listing rules; delisting risk persists if the stock does not regain compliance by December 9, 2026.
Price Chart
Executive Summary
Adagio Medical Holdings, Inc. is holding a special meeting on October 23, 2026, to seek stockholder approval for a reverse stock split at a ratio between 1-for-10 and 1-for-500, to be determined by the Board. The company is not in compliance with Nasdaq's minimum bid price ($1.00) and stockholders' equity ($2.5M) requirements, and faces potential delisting. The filing is a routine governance measure to regain compliance, with no financial data, executive compensation, or shareholder proposals disclosed.
Key Facts
- Special meeting on October 23, 2026, to vote on a reverse stock split at a ratio of 1-for-10 to 1-for-500.
- Company received Nasdaq deficiency notices on June 12, 2026 (bid price <$1.00) and August 13, 2026 (stockholders' equity <$2.5M).
- As of October 5, 2026, there were 27,439,328 shares of common stock outstanding and entitled to vote.
- As of September 30, 2026, there were 26,489,328 shares issued and outstanding, with 51 stockholders of record.
- Top holders: Perceptive Advisors LLC (47.98%) and Alyeska Master Fund, L.P. (9.26%).
- No executive compensation details, director elections, shareholder proposals, or related party transactions are included in this filing.
Financial Impact
No financial figures reported; the reverse stock split is intended to raise per-share price to meet Nasdaq's $1.00 minimum bid requirement.
Risk Factors
- Potential Nasdaq delisting if the reverse stock split fails to raise the stock price above $1.00 per share for 10 consecutive days.
- Stockholders with fewer than the split ratio may be cashed out and cease to be a stockholder.
- The reverse stock split may not increase the stock price proportionally and could decrease market capitalization.
- The reverse stock split may have an anti-takeover effect due to increased authorized but unissued shares.
- No guarantee that the stock price will attract institutional investors or institutional investors.
- The company may not regain compliance with Nasdaq's minimum stockholders' equity requirement of $2,500,000.
- The reverse stock split may result in a significant devaluation of the stock price and may not be greater than the absence of a reverse stock split.
- The company may not be able to obtain financing for the continuation of operations or exploration of strategic alternatives.
- The company may lose confidence in the company if the stock is delisted.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001140361-26-039339 |
| Document: 0001140361-26-039339-index-headers.html | 0001140361-26-039339 |
| Document: 0001140361-26-039339-index.html | 0001140361-26-039339 |
| Document: 0001140361-26-039339.txt | 0001140361-26-039339 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | DEF 14A | $0.1253 $0.1208 | ▼ −3.59% | ▼ −2.44% | $0.0980 (−21.79%) |
Oct 1, 2026 24d ago | 8-K | $0.1531 $0.1300 | ▲ +15.09% | ▲ +16.25% | $0.0980 (+35.99%) |
Sep 23, 2026 4w ago | 8-K | $0.2280 $0.1530 | ▲ +32.89% | ▲ +32.22% | $0.0980 (+57.02%) |
Aug 11, 2026 10w ago | 8-K | $0.7190 $0.6460 | ▲ +10.15% | ▲ +9.75% | $0.0980 (+86.37%) |
Jul 13, 2026 15w ago | 10-K/A | $0.5710 $0.5300 | ▼ −7.18% | ▼ −6.40% | $0.0980 (−82.84%) |
May 21, 2026 22w ago | 8-K | $0.8410 $0.7699 | ▼ −8.45% | ▼ −10.13% | $0.0980 (−88.35%) |
May 12, 2026 23w ago | 8-K | $0.9230 $0.8830 | ▼ −4.33% | ▼ −4.41% | $0.0980 (−89.38%) |
Apr 27, 2026 26w ago | 8-K | $1.15 $0.9410 | ▼ −18.17% | ▼ −18.57% | $0.0980 (−91.48%) |
Apr 8, 2026 28w ago | 8-K | $1.41 $1.43 | ▲ +1.42% | ▼ −2.10% | $0.0980 (−93.05%) |
Apr 6, 2026 29w ago | EFFECT | $1.25 $1.33 | ▼ −6.40% | ▼ −2.27% | $0.0980 (+92.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers